Weight Loss
-
268The process of raising US$700 million to start Karnalyte’s potash mine in Saskatchewan
A lot of creativity was expected to generate US$700 million indebted and equity to complement regarding a potash mine in Saskatchewan. Creativity...
-
257Global stocks stable, oil rises, U.S. dollar rallies as world awaits Fed decision
The dollar extended its best run of gains in a month and oil rallied before the Federal Reserve’s policy review on Wednesday...
-
296S&P 500 rally is here and it’s time to sell, says Citi
Following the lows in the January and February of the season, analysts at Citigroup told investors to handle for your inevitable rally...
-
335WestJet’s turf war with Air Canada creates ‘paradox’ for investors: Raymond James analyst
WestJet Airlines Ltd. is developing a “paradox” for investors by escalating its turf war with Air Canada, putting pressure on yields and...
-
202Valeant Pharmaceuticals International Inc analyst now most bearish
There can be a new low for analyst price targets on Valeant Pharmaceuticals International Inc. Irina Koffler at Mizuho Securities USA downgraded...
-
207Why budget day bets on infrastructure stocks may not pay off
Planned increases for infrastructure spending in Tuesday’s federal budget should benefit numerous Canadian companies, but investors attempting to play in the sector...
-
201Why the Fed should ditch the ‘dot plot’ and rate guidance
Labeling the federal government Reserve’s guidance “awful” and “highly misleading,” Scotiabank is looking for that central bank to cease publication of the...
-
216Recovery of loonie and oil prices set stage for ‘worst of both worlds’ scenario
The recovery in oil prices as well as the Canadian dollar is setting happens for just about any “worst of both worlds”...
-
247How determination and patience helped Karnalyte Resources secure a US$700M financing deal with its Indian partner
There are stories, great stories its keep may be the book that is required to summarize the best Few years at Calgary-based...
-
278Burned again, investor faith in former market darling Valeant Pharmaceuticals International Inc falters
Stakeholders are losing their faith in Valeant Pharmaceuticals International Inc. carrying out a company’s worst-ever day loss, whilst among its largest holders...
